Venus Concept Corporation (VERO): Enterprise Value to EBITDA Ratio
The market trend for Venus Concept Inc. (VERO) visualized in monetary terms demonstrates the 0.00 indicator. The business relies on creating a comprehensive environment for cosmetology, combining the sale of modern devices with ancillary services. Venus Concept Inc. (VERO) maintains its position as a global leader by developing intelligent energy management systems and robotics. However, loan costs and declining demand for premium services are undermining its financial stability.
Comprehensive metric breakdowns and analytics for venusconcept.com (VERO)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Venus Concept Inc.|VERO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Venus Concept|VERO - Company Total Debt|Debts to Book Capitalization Venus Concept Corporation|VERO - Long-Term Debt|Company Short-Term Debts Venus Concept|Quick Ratio venusconcept.com
- financial results and valuation multiples details:
VERO - Net Financial Result|Projected Future Earnings Venus Concept Inc.|VERO - Price to Earnings Ratio|Forward P/E Multiple Venus Concept Inc.|VERO - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Venus Concept Corporation|VERO - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Venus Concept|VERO - Earnings per share for the trailing year|Quarterly EPS earnings growth venusconcept.com|VERO - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Venus Concept Inc.
Analysis of all company metrics:Venus Concept Corp VERO
The outsourcing model of Venus Concept Inc. (VERO) minimizes capital expenditures, which directly impacts the EV/EBITDA metric accounting for debt and amortization. This metric correlates the total enterprise value, including net debt, with its operating profit before taxes, depreciation, and amortization. Analyzing this ratio allows for an assessment of the real asset value and the investment payback period under conditions of high debt leverage.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|SNWV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OM|ELMD (SmartVest) - EV/EBITDA Multiple|LENSAR Inc. (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio profoundmedical.com PROF|EV/EBITDA Multiple BDMD (Baird Medical)|EV/EBITDA Multiple EDAP TMS SA EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (pulmonx.com) - Enterprise Value to EBITDA Ratio|TELA Bio - Business Value to Operating Income Before Depreciation|CTSO (CytoSorbents Corp) - EV/EBITDA Multiple|Company Value to EBITDA sensushealthcare.com SRTS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zynex (ZYXI)|electrocore.com (ECOR) - Enterprise Value to EBITDA Multiple|Vicarious Surgical - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Inspira Technologies Oxy B.H.N. Ltd. IINN|SeaStar Medical Holding - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio IRIDEX Corporation IRIX|ibs.inc (INBS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XAIR (Beyond Air)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Profusa, Inc.|Enterprise Value to EBITDA Ratio STRATA Skin (SSKN)|EV/EBITDA Multiple GCTK|NAOV - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM (BioSig Technologies, Inc.) - Enterprise Value to EBITDA Ratio|CUTR (cutera.com) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KNW (Know Labs) - EV/EBITDA Multiple|Company Value to EBITDA Inari Medical Inc NARI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nevro Corporation (NVRO)|reshapelifesciences.com - Enterprise Value to Operating Income Before Depreciation|Silk Road Medical, Inc - Enterprise Value to EBITDA Ratio
